Experience of Using Everolimus in the Early Stage of Living Donor Liver Transplantation

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Klemens Budde, Thomas Becker, Wolfgang Arns et al. · The Lancet · 2011 · 356 citations

Medicine, Nephrology, Surgery +14

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial

Paolo De Simone, Frank Nevens, Luciano De Carlis et al. · American Journal of Transplantation · 2012 · 329 citations · Full text

Medicine, Pharmacotherapy, Surgery +17

Everolimus Plus Reduced‐Exposure CsA versus Mycophenolic Acid Plus Standard‐Exposure CsA in Renal‐Transplant Recipients

Diane M. Cibrik, Thomas Johnston, Eva Lacková et al. · American Journal of Transplantation · 2010 · 269 citations · Full text

Medicine, Nephrology, Pharmacology +12

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma

Michael A. Zimmerman, James F. Trotter, Michael Wachs et al. · Liver Transplantation · 2008 · 206 citations

Pharmacy, Oncology, Pharmacotherapy +16

A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation—PROTECT

Lutz Fischer, J. Klempnauer, Susanne Beckebaum et al. · American Journal of Transplantation · 2012 · 189 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17